$0.4481
0.03227.74%
Ult. Agg.: Oct 27, 6:16 PM
Redhill Biopharma (RDHL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Redhill Biopharma (RDHL) ha pubblicato l'ultima guidance il marzo 6, 2023 per Q4 2022. La società ha previsto un fatturato pari a $13.5M - $15.5M per il periodo.
| Metric | H1 '26 | H1 '25 | H1 '24 | Q2 '23 | FY '25 | FY '24 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | — | — | — | — | — | — |
| Actual | $0.00 | $0.00 | $0.00 | $2.25 | $0.00 | $0.00 |
| Surprise | — | — | — | — | — | — |
| Revenue | ||||||
| Estimate | — | — | — | — | — | — |
| Actual | $0 | $4.1M | $2.6M | $1.8M | $286000 | $8.0M |
| Surprise | — | — | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q1 | Jun 23, 2022 | $-300.00 | $-230.00 | -30.4 % |
| Q4 | Mar 17, 2022 | $-500.00 | $-330.00 | -51.5 % |
| Q3 | Nov 30, 2021 | $-500.00 | $-210.00 | -138.1 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | Apr 28, 2023 | $12.80M | $18.10M | -29.3 % |
| Q3 | Nov 29, 2022 | $17.55M | $21.24M | -17.4 % |
| Q1 | Jun 23, 2022 | $18.24M | $24.30M | -24.9 % |
| Q4 | Mar 17, 2022 | $22.07M | $24.08M | -8.34 % |